Does fetal growth restriction lead to increased brain injury as detected by neonatal cranial ultrasound in premature infants?. (4th May 2015)

• Record Type: Journal Article
• Authors: Malhotra, Atul; Yahya, Zamir; Sasi, Arun; Jenkin, Graham; Ditchfield, Michael; Polglase, Graeme R; Miller, Suzanne L
• Is Part Of: Journal of paediatrics and child health. Volume 51:Number 11(2015:Nov.)
• Page Start: 1103
• Page End: 1108
• Publication Date: 2015-05-04
• Subjects: IUGR -- neonate -- neuroimaging -- outcome; Children -- Health and hygiene -- Periodicals; Pediatrics -- Periodicals; 618.92
• DOI: 10.1111/jpc.12910
• Languages: English
• ISSNs: 1034-4810

Abstract

Abstract : Aim: Intra‐uterine growth restriction (IUGR) is an important cause for prematurity as well as a significant risk factor for neurodevelopmental deficits. In this study, we aimed to examine the association between IUGR and early brain injury on neonatal cranial ultrasound in preterm infants. Methods: This retrospective cohort study examined the relationship between IUGR and neonatal cranial ultrasound findings in preterm infants <32 weeks gestation with IUGR, compared with gestation and year of birth‐matched appropriately grown infants, in a tertiary level neonatal unit. Primary outcome was incidence and severity of intraventricular haemorrhage (IVH), periventricular leucomalacia (PVL) and hydrocephalus detected by cranial ultrasound in the neonatal period. Results: A total of 153 IUGR and 306 non‐IUGR preterm infants <32 weeks were included. The rates of IVH (21.6% vs. 23.9%), severe IVH (3.9% vs. 4.6%), PVL (8.4% vs. 9.4%), cystic PVL (2.6% vs. 0%) and hydrocephalus (0.7% vs. 0.3%) were similar in the two groups. Composite outcome of death and severe brain injury (severe IVH, cystic PVL and hydrocephalus) was greater (20.2% vs. 9.1%, P = 0.001) in IUGR infants. Conclusion: IUGR did not lead to increased neonatal brain injury on cranial ultrasound but was associated with increased mortality. Advanced neonatal neuroimaging techniques may be necessary to estimate risk and to provide prognostic information of adverse neurological outcomes in this vulnerable population.